Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of compound and synthesis method, which is applied in the field of medicine and chemical industry, can solve the problems of long steps and limitations of industrial production, and achieve the effect of less by-products, short method route and mild reaction conditions
Active Publication Date: 2021-01-08
山东鲁宁药业有限公司
View PDF8 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
This route needs to use sodium azide and the steps are long, and industrial production has certain restrictions
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0020] The synthesis of embodiment 1. compound 3:
[0021] Compound 1 (7.4g, 40mmol), compound 2 (5.9g, 40mmol), Na 2 CO 3 (2M, 80 mmol, ), Pd(dppf)Cl 2 (2mmol) and 150mL of ethylene glycol dimethyl ether were added successively in a 500mL flask under a nitrogen atmosphere, refluxed for 2 hours, then extracted with ethyl acetate, NaHCO3 solution, brine were washed successively, dried over anhydrous magnesium sulfate, filtered, The crude product obtained by concentration was directly used in the next step without purification.
Embodiment 2
[0022] The synthesis of embodiment 2. compound 5:
[0023] Compound 4 (9.0g, 41mmol), Na 2 CO 3 (8.7g, 82mmol), compound 3 (8.1g, crude product) and 150mL of DMF were added to a 250mL flask, reacted at 130°C for 2h, cooled, concentrated, diluted with water, extracted with ethyl acetate, dried, and purified by column chromatography 5 (13g, yield, 80%)
Embodiment 3
[0024] The synthesis of embodiment 3. compound 6:
[0025] SnCl 2 (10g, 54mmol) was added in the ethyl acetate (300mL) solution of compound 5 (13g, 32mmol), then refluxed for 17h, after monitoring that the reaction was complete, direct concentration column chromatography purified to obtain compound 6 (10.5g, yield 87%)
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention relates to a preparation method for azilsartan. The method is characterized by comprising the following steps: enabling 2-fluorine-3-bromine nitrobenzene to react with a midbody 3 prepared from suzuki reaction, replacing 2 fluorines and then reducing by nitro group; reacting with tetraethyl orthocarbonate, closing the ring and forming a benzimidazole ring; reacting with hydroxylamine hydrochloride and compounding a phenyl substituted oxadiazole ring under the effect of CDI; forming formic acid with carbon dioxide under the catalysis of n-butyllithium, thereby acquiring the product. The preparation method has the advantages of easily acquired raw materials, simple process, high overall yield, few side products, simplicity in post-processing and suitability for industrial production.
Description
technical field [0001] The invention belongs to the field of medicine and chemical industry, in particular to a method for synthesizing Azilsartan. Background technique [0002] Azilsartan is a new type of antihypertensive drug developed by Japan's Takeda Pharmaceutical Company. Its trade name is Edabi. The patent protection period is until 2025. It belongs to the 3.1 new drug category of chemical drugs. It was approved for marketing by the US FDA in February 2011, and was approved for marketing in Japan on January 28, 2012. It is suitable for antihypertensive clinically, and can competitively and reversibly block the combination of angiotensin and AT1 receptors to lower blood pressure. It is superior to valsartan and olmesartan in antihypertensive aspects, and is used in the clinic. As the prodrug of azilsartan medoxomil, after oral administration, it will be hydrolyzed into azilsartan by aromatic esterase in the gastrointestinal tract or plasma, and has a strong and long...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more